The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- Pengfei Jin
- Yaru Quan
- Xuefeng Gao
- Mingwei Wei
- Xiang Cao
- Hongxing Pan
- Heng Shen
- Lei Zhao
- Qing Xu
- Zhao Wang
- Xiaodong Liu
- Jinmei Xu
- Kangwei Xu
- Wenyan Wan
- Yeqing Tong
- Li Zhang
- Songtao Xu
- Jingxin Li
2026-08-07